These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11968220)

  • 21. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Para-aminosalicylic acid (PAS) desensitization review in a case of multidrug-resistant pulmonary tuberculosis.
    Wilson JW; Kelkar P; Frigas E
    Int J Tuberc Lung Dis; 2003 May; 7(5):493-7. PubMed ID: 12757053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Starting with camphor--the progress of Nippon Fine Chemical].
    Kimura O
    Yakushigaku Zasshi; 2010; 45(1):71-7. PubMed ID: 21032891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taltirelin (Tanabe Seiyaku).
    Brown WM
    IDrugs; 2001 Dec; 4(12):1389-400. PubMed ID: 15931571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of veterinary antiparasitic agents in the 21st century: a view from industry.
    Woods DJ; Knauer CS
    Int J Parasitol; 2010 Aug; 40(10):1177-81. PubMed ID: 20430031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: Pathogenetic theory of tuberculosis].
    Munakata M
    Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1708-9. PubMed ID: 12170730
    [No Abstract]   [Full Text] [Related]  

  • 28. Perspectives: biotechnology in Czech Republic, the past and the future.
    Damborský J; Prokop Z; Kostka M
    Biotechnol J; 2006 May; 1(5):487-90. PubMed ID: 16892283
    [No Abstract]   [Full Text] [Related]  

  • 29. [The history and the latest trend of the occupational diseases in Japan].
    Endo G
    Nihon Rinsho; 2014 Feb; 72(2):198-203. PubMed ID: 24605515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A hundred years of Gedeon Richter Ltd].
    Pillich L
    Acta Pharm Hung; 2002; 72(1):9-14. PubMed ID: 12426783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis - historical development, current status, future prospects].
    Loddenkemper R; Diel R; Schaberg T
    Pneumologie; 2010 Sep; 64(9):567-72. PubMed ID: 20827640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
    Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dr. Kazuyuki Tanabe: an explorer for the secret life of malaria parasites.
    Kojima S
    Parasitol Int; 2015 Jun; 64(3):xvi. PubMed ID: 25463309
    [No Abstract]   [Full Text] [Related]  

  • 34. TWENTY YEARS AFTERWARD HISTORICAL NOTES ON THE DISCOVERY OF THE ANTITUBERCULOSIS EFFECT OF PARAAMINOSALICYLIC ACID (PAS) AND THE FIRST CLINICAL TRIALS.
    LEHMANN J
    Am Rev Respir Dis; 1964 Dec; 90():953-6. PubMed ID: 14233801
    [No Abstract]   [Full Text] [Related]  

  • 35. [Historical study of moth repellent, "Fujisawa Camphor" (6) - manufacturing and selling of "Fujisawa Camphor" during World War II.].
    Hattori A
    Yakushigaku Zasshi; 2005; 40(1):22-28. PubMed ID: 16217903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An early history of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):659-64. PubMed ID: 18675760
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmaceutical industry, public hygiene, and health at the turn of the century].
    Lefebvre T
    Rev Hist Pharm (Paris); 1996; 44(312 suppl):283-5. PubMed ID: 11618653
    [No Abstract]   [Full Text] [Related]  

  • 38. In brief. Historical indications for the surgical treatment of tuberculosis.
    Pezzella AT; Fang W
    Curr Probl Surg; 2008 Nov; 45(11):766-9. PubMed ID: 18809086
    [No Abstract]   [Full Text] [Related]  

  • 39. The story so far in R&D.
    Prous JR; Khurdayan VK
    Drug News Perspect; 2007; 20(1):7-15. PubMed ID: 17332897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory role in tuberculosis control.
    Wand P
    WMJ; 2003; 102(6):31-4. PubMed ID: 14658565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.